4//SEC Filing
Clendening John S 4
Accession 0001068875-19-000093
CIK 0001068875other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 5:04 PM ET
Size
9.4 KB
Accession
0001068875-19-000093
Insider Transaction Report
Form 4
BLUCORA, INC.BCOR
Clendening John S
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2019-10-07$4.98/sh+37,500$186,750→ 704,467 total - Sale
Common Stock
2019-10-07$21.20/sh−54,250$1,150,100→ 650,217 total - Exercise/Conversion
Stock Option (Right to Buy)
2019-10-07−37,500→ 11,999 totalExercise: $4.98Exp: 2023-04-04→ Common Stock (37,500 underlying)
Footnotes (4)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2018.
- [F2]The price reported in Column 4 is a weighted average price. These shares sold in multiple transactions at prices ranging from $21.04 to $21.41. Upon request by the SEC staff, the issuer or any security holder of the issuer, the reporting person will provide the full information regarding the number of shares sold at each separate price.
- [F3]Not included in this amount are 119,132 performance-based restricted stock units of which (i) 12,906 are eligible to vest following May 6, 2020, (ii) 43,750 are eligible to vest from 0% to 200% following the end of 2020 and (iii) 62,476 are eligible to vest from 0% to 200% following the end of 2021. Vesting for each award is subject to the issuers achievement of certain financial goals and certification by the Compensation Committee.
- [F4]15% of the total option vested on April 4, 2016. The remainder vested 33.33% on April 4, 2017 and approximately 16.67% vested at the end of each six month period thereafter, such that the option was fully vested on April 4, 2019.
Documents
Issuer
BLUCORA, INC.
CIK 0001068875
Entity typeother
Related Parties
1- filerCIK 0001388961
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 5:04 PM ET
- Size
- 9.4 KB